Potassium Chloride And Sodium Chloride

Generic Name: potassium chloride and sodium chloride

Over-the-Counter (OTC)

Brand Names:

Potassium Chloride In Sodium Chloride

DESCRIPTION Potassium Chloride in Sodium Chloride Injection, USP is a sterile, nonpyrogenic, solution for fluid and electrolyte replenishment in a single dose container for intravenous administration. It contains no antimicrobial agents. Composition, osmolarity, pH and ionic concentration are shown in Table 1. Table 1 Size (mL) Composition (g/L) Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L.

Overview

DESCRIPTION Potassium Chloride in Sodium Chloride Injection, USP is a sterile, nonpyrogenic, solution for fluid and electrolyte replenishment in a single dose container for intravenous administration. It contains no antimicrobial agents. Composition, osmolarity, pH and ionic concentration are shown in Table 1. Table 1 Size (mL) Composition (g/L) Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L.

Uses

INDICATIONS AND USAGE Potassium Chloride in Sodium Chloride Injection, USP is indicated as a source of water and electrolytes.

Dosage

DOSAGE AND ADMINISTRATION Important Administration Instructions • Potassium Chloride in Sodium Chloride Injection, USP is intended for intravenous infusion using sterile equipment. • To avoid life threatening hyperkalemia, do not administer Potassium Chloride in Sodium Chloride Injection, USP as an intravenous push (i.e., intravenous injection manually with a syringe connected to the intravenous access) without a quantitative infusion device (see WARNINGS ). • Do not connect flexible plastic containers in series in order to avoid air embolism due to possible residual air contained in the primary container. • Set the vent to the closed position on a vented intravenous administration set to prevent air embolism. • Use a dedicated line without any connections to avoid air embolism.

Side Effects

ADVERSE REACTIONS The following adverse reactions associated with the use of Potassium Chloride in Sodium Chloride Injection, USP were identified in clinical trials or postmarketing reports. Because postmarketing reactions were reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency, reliably, or to establish a causal relationship to drug exposure. General disorders and administration site condition s: Chills, and infusion site pain. Hypersensitivity reactions : generalized papules and erythema, rash, fever, vomiting, hypertension, tachycardia. Metabolism and nutrition disorders : Hyperkalemia, hyponatremia, hypernatremia, hyperchloremia acidosis, fluid overload.

Interactions

Drug Interactions Lithium Renal sodium and lithium clearance may be increased during administration of Potassium Chloride in Sodium Chloride Injection, USP and result in decreased lithium concentrations. Monitor serum lithium concentrations during concomitant use. Other Products that Cause Hyperkalemia Administration of Potassium Chloride in Sodium Chloride Injection, USP in patients treated concurrently or recently with products that are associated with hyperkalemia increases the risk of severe and potentially fatal hyperkalemia, in particular in the presence of other risk factors for hyperkalemia.

Warnings

WARNINGS Hypersensitivity Hypersensitivity and infusion reactions, including anaphylaxis and chills, have been reported with products containing potassium chloride and sodium chloride. Stop the infusion immediately if signs or symptoms of a hypersensitivity or infusion reaction develops. Appropriate therapeutic countermeasures must be instituted as clinically indicated. Electrolyte Imbalances Hyperkalemia Potassium-containing solutions, including Potassium Chloride in Sodium Chloride Injection, USP may increase the risk of hyperkalemia. Hyperkalemia can be asymptomatic and manifest only by increased serum potassium concentrations and/or characteristic electrocardiographic (ECG) changes. CONTRAINDICATIONS Potassium Chloride in Sodium Chloride Injection, USP is contraindicated in patients with: • Known hypersensitivity to potassium chloride and/or sodium chloride (see WARNINGS ). • Clinically significant hyperkalemia (see WARNINGS ).

Pregnancy

Pregnancy There are no adequate and well controlled studies from the use of Potassium Chloride in Sodium Chloride Injection, USP in pregnant or lactating women and animal reproduction studies have not been conducted with this drug. Therefore, it is also not known whether Potassium Chloride in Sodium Chloride Injection, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Potassium Chloride in Sodium Chloride Injection, USP should be given to a pregnant woman only if the potential benefit justifies the potential risk to the fetus.

Storage

HOW SUPPLIED Potassium Chloride in Sodium Chloride Injection, USP in VIAFLEX Plus Plastic Container is available as follows: Code Size (mL) NDC Product Name 2B1357 1000 0338-0704-34 20 mEq/L Potassium Chloride in 0.45% Sodium Chloride Injection, USP 2B1764 1000 0338-0691-04 20 mEq/L Potassium Chloride in 0.9% Sodium Chloride Injection, USP 2B1984 1000 0338-0695-04 40 mEq/L Potassium Chloride in 0....

Frequently Asked Questions

What is Potassium Chloride And Sodium Chloride used for?

INDICATIONS AND USAGE Potassium Chloride in Sodium Chloride Injection, USP is indicated as a source of water and electrolytes.

What are the side effects of Potassium Chloride And Sodium Chloride?

ADVERSE REACTIONS The following adverse reactions associated with the use of Potassium Chloride in Sodium Chloride Injection, USP were identified in clinical trials or postmarketing reports. Because postmarketing reactions were reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency, reliably, or to establish a causal relationship to drug exposure. General disorders and administration site condition s: Chills, and infusion site pain. Hypersensitivity reactions : generalized papules and erythema, rash, fever, vomiting, hypertension, tachycardia. Metabolism and nutrition disorders : Hyperkalemia, hyponatremia, hypernatremia, hyperchloremia acidosis, fluid overload.

Can I take Potassium Chloride And Sodium Chloride during pregnancy?

Pregnancy There are no adequate and well controlled studies from the use of Potassium Chloride in Sodium Chloride Injection, USP in pregnant or lactating women and animal reproduction studies have not been conducted with this drug. Therefore, it is also not known whether Potassium Chloride in Sodium Chloride Injection, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Potassium Chloride in Sodium Chloride Injection, USP should be given to a pregnant woman only if the potential benefit justifies the potential risk to the fetus.

What are the important warnings for Potassium Chloride And Sodium Chloride?

WARNINGS Hypersensitivity Hypersensitivity and infusion reactions, including anaphylaxis and chills, have been reported with products containing potassium chloride and sodium chloride. Stop the infusion immediately if signs or symptoms of a hypersensitivity or infusion reaction develops. Appropriate therapeutic countermeasures must be instituted as clinically indicated. Electrolyte Imbalances Hyperkalemia Potassium-containing solutions, including Potassium Chloride in Sodium Chloride Injection, USP may increase the risk of hyperkalemia. Hyperkalemia can be asymptomatic and manifest only by increased serum potassium concentrations and/or characteristic electrocardiographic (ECG) changes. CONTRAINDICATIONS Potassium Chloride in Sodium Chloride Injection, USP is contraindicated in patients with: • Known hypersensitivity to potassium chloride and/or sodium chloride (see WARNINGS ). • Clinically significant hyperkalemia (see WARNINGS ).

Related Medications

Lobelia Inflata, Strychnos Ignatii Seed, Avena Sativa Flowering Top, Dibasic Potassium Phosphate, Selenicereus Grandiflorus Stem, Glutamine, Taurine, And Thiamine Hydrochloride

lobelia inflata, strychnos ignatii seed, avena sativa flowering top, dibasic potassium phosphate, selenicereus grandiflorus stem, glutamine, taurine, and thiamine hydrochloride

Amino Acid [EPC]

Alcohol, nicotine and morphine addiction.

Calendula Officinalis, Hamamelis Virginiana, Arnica Montana, Hypericum Perforatum, Symphytum Officinale, Bellis Perennis, Ledum Palustre, Millefolium, Sulphuricum Acidum, Belladonna, Calcarea Fluorica, Ferrum Phosphoricum, Rhus Tox, Ruta Graveolens, Calcarea Carbonica, Natrum Sulphuricum

calendula officinalis, hamamelis virginiana, arnica montana, hypericum perforatum, symphytum officinale, bellis perennis, ledum palustre, millefolium, sulphuricum acidum, belladonna, calcarea fluorica, ferrum phosphoricum, rhus tox, ruta graveolens, calcarea carbonica, natrum sulphuricum

Dosage form: LIQUID. Active ingredients: ACHILLEA MILLEFOLIUM WHOLE (12 [hp_X]/kg); ARNICA MONTANA WHOLE (1 [hp_X]/kg); ATROPA BELLADONNA (30 [hp_X]/kg); BELLIS PERENNIS WHOLE (12 [hp_X]/kg); CALCIUM FLUORIDE (30 [hp_X]/kg); CALENDULA OFFICINALIS FLOWERING TOP (1 [hp_X]/kg); COMFREY ROOT (6 [hp_X]/kg); FERROSOFERRIC PHOSPHATE (30 [hp_X]/kg); HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK (1 [hp_X]/kg); HYPERICUM PERFORATUM WHOLE (1 [hp_X]/kg); OYSTER SHELL CALCIUM CARBONATE, CRUDE (30 [hp_C]/kg); RHOD

Calcium Carbonate, Magnesium Hydroxide, Simethicone

calcium carbonate, magnesium hydroxide, simethicone

Purposes Antacid Antigas

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.